150 related articles for article (PubMed ID: 33447308)
1. Mechanism and Effect of Beta-Blockers on Pancreatic Adenocarcinoma: A Literature Review.
Upadhyaya VD; Douedi S; Garcia B; Gonzalez J; Udongwo N; Wei J; Nai Q; Asif A; Sen S
J Clin Med Res; 2020 Dec; 12(12):753-757. PubMed ID: 33447308
[TBL] [Abstract][Full Text] [Related]
2. Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma.
Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Cancer Res; 2017 Jul; 77(13):3700-3707. PubMed ID: 28473530
[TBL] [Abstract][Full Text] [Related]
3. The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors.
Askari MD; Tsao MS; Schuller HM
J Cancer Res Clin Oncol; 2005 Oct; 131(10):639-48. PubMed ID: 16091975
[TBL] [Abstract][Full Text] [Related]
4. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.
Coelho M; Soares-Silva C; Brandão D; Marino F; Cosentino M; Ribeiro L
J Cancer Res Clin Oncol; 2017 Feb; 143(2):275-291. PubMed ID: 27709364
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of β-blockers on human colorectal cancer cells.
Coelho M; Moz M; Correia G; Teixeira A; Medeiros R; Ribeiro L
Oncol Rep; 2015 May; 33(5):2513-20. PubMed ID: 25812650
[TBL] [Abstract][Full Text] [Related]
6. β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis.
Childers WK; Hollenbeak CS; Cheriyath P
Clin Breast Cancer; 2015 Dec; 15(6):426-31. PubMed ID: 26516037
[TBL] [Abstract][Full Text] [Related]
7. Neural Regulation of Pancreatic Cancer: A Novel Target for Intervention.
Chang A; Kim-Fuchs C; Le CP; Hollande F; Sloan EK
Cancers (Basel); 2015 Jul; 7(3):1292-312. PubMed ID: 26193320
[TBL] [Abstract][Full Text] [Related]
8. β-adrenergic-blocking drugs and melanoma: current state of the art.
De Giorgi V; Grazzini M; Gandini S; Benemei S; Asbury CD; Marchionni N; Geppetti P
Expert Rev Anticancer Ther; 2012 Nov; 12(11):1461-7. PubMed ID: 23249110
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Role of G Protein-coupled Receptors in Pancreatic Cancer Development and Progression.
Schuller HM
Curr Med Chem; 2018; 25(22):2566-2575. PubMed ID: 28260499
[TBL] [Abstract][Full Text] [Related]
10. The cellular and physiologic effects of beta blockers in heart failure.
Sabbah HN
Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.
Lin X; Luo K; Lv Z; Huang J
Hepatogastroenterology; 2012; 59(114):584-8. PubMed ID: 22353526
[TBL] [Abstract][Full Text] [Related]
12. Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarcinoma: An AGEO multicentric retrospective cohort.
Kourie H; Auclin E; Cunha AS; Gaujoux S; Bruzzi M; Sauvanet A; Lourenco N; Trouilloud I; Louafi S; El-Hajjar A; Vaillant JC; Smith D; Touchefeu Y; Bachet JB; Pietrasz D; Taieb J
Clin Res Hepatol Gastroenterol; 2019 Nov; 43(6):663-668. PubMed ID: 31029644
[TBL] [Abstract][Full Text] [Related]
13. β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.
Zhang D; Ma QY; Hu HT; Zhang M
Cancer Biol Ther; 2010 Jul; 10(1):19-29. PubMed ID: 20424515
[TBL] [Abstract][Full Text] [Related]
14. Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment.
Lama PJ
Am J Ophthalmol; 2002 Nov; 134(5):749-60. PubMed ID: 12429254
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
16. Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.
Sahin IH; Iacobuzio-Donahue CA; O'Reilly EM
Expert Opin Ther Targets; 2016; 20(3):341-59. PubMed ID: 26439702
[TBL] [Abstract][Full Text] [Related]
17. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
Yokota Y
J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Pancreatic Adenocarcinoma in Elderly Patients over 75 Years of Age: A Retrospective Series of 129 Patients.
Oziel-Taieb S; Faure M; Gilabert M; Autret A; Turrini O; Moureau-Zabotto L; Giovannini M; Rousseau F; Raoul JL
J Gastrointest Cancer; 2016 Mar; 47(1):15-9. PubMed ID: 26545612
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic blockers in heart failure: review of mechanisms of action and clinical outcomes.
Satwani S; Dec GW; Narula J
J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):243-55. PubMed ID: 15678243
[TBL] [Abstract][Full Text] [Related]
20. Higher notch expression implies poor survival in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Ye J; Wen J; Ning Y; Li Y
Pancreatology; 2018 Dec; 18(8):954-961. PubMed ID: 30297095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
